BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3992094)

  • 1. [Experience with calcitonin in the treatment of peripheral arterial occlusive diseases and coronary heart disease].
    Staehelin A; Staehelin GA; Sturzenegger J
    Schweiz Rundsch Med Prax; 1985 Mar; 74(13):333-5. PubMed ID: 3992094
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
    Leschke M; Schoebel FC; Strauer BE
    Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of arterial thromboembolic disease.
    Meyer BJ; Chesebro JH
    Curr Opin Hematol; 1994 Sep; 1(5):336-40. PubMed ID: 9371302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A treatment possibility of arterial occlusive diseases with calcitonin. Retrospect of 16 years experience in over 200 patients between 20 and 99 years of age].
    Staehelin A; Weidmann M; Staehelin E; Horat R
    Vasa Suppl; 1988; 26():194-6. PubMed ID: 3201373
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 6. GUSTO: is science or money talking?
    Jackson G
    Br J Clin Pract; 1993; 47(4):175. PubMed ID: 8260330
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological and therapeutic effects of nicotinic acid unrelated to the vitamin activity].
    Condorelli L
    Acta Vitaminol Enzymol; 1977; 31(1-5):57-84. PubMed ID: 580690
    [No Abstract]   [Full Text] [Related]  

  • 8. [Patients with arterial occlusive disease die of myocardial infarct or stroke. The dangerous sisters: arterial occlusive disease and coronary heart disease].
    MMW Fortschr Med; 2004; 146 Suppl 1():6-7. PubMed ID: 15493409
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the status of coronary revascularization for acute myocardial infarction?
    Pluth JR
    Cardiovasc Clin; 1983; 13(1):183-90. PubMed ID: 6401227
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin in vascular pathology--therapeutic possibilities.
    Gryglewski RJ; Szczeklik A
    Ann Clin Res; 1984; 16(5-6):253-61. PubMed ID: 6398663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of antithrombotic drugs in the treatment of peripheral occlusive arterial diseases].
    Violi F
    Minerva Cardioangiol; 1999 Nov; 47(11):416. PubMed ID: 10681239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progesterone in fibromatosis and atherosclerosis].
    Lanari A
    Medicina (B Aires); 1979; 39(6):826-35. PubMed ID: 550047
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the coronary risk in sclerotic arterial diseases of the lower limbs].
    Thomas D
    Rev Prat; 1995 Jan; 45(1):44-9. PubMed ID: 7725008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical therapy in peripheral arterial occlusive disease].
    Périard D; Hayoz D; Mazzolai L
    Rev Med Suisse; 2009 Feb; 5(189):312-5. PubMed ID: 19271648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombophilias and peripheral arterial occlusive disease].
    Le Hello C; Blacher J; Conard J; Piette JC; Constans J
    J Mal Vasc; 2008 Sep; 33(3):126-36. PubMed ID: 18554834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the plasma concentration of some lipid fractions in patients treated with arterial wall extract].
    Natale L
    Clin Ter; 1974 Jul; 70(1):17-62. PubMed ID: 4408827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombotic therapy and follow-up of peripheral arterial occlusive disease].
    Breddin HK
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):633-8. PubMed ID: 10666826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of occlusive peripheral arterial disease of the lower limbs].
    Ponsonnaille J
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1177-8. PubMed ID: 16435594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.